The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Author:
Funder
Biogen
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Link
http://link.springer.com/article/10.1007/s00415-017-8594-9/fulltext.html
Reference194 articles.
1. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517. doi: 10.1016/S0140-6736(08)61620-7
2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952. doi: 10.1056/NEJM200009283431307
3. Barten LJ, Allington DR, Procacci KA, Rivey MP (2010) New approaches in the management of multiple sclerosis. Drug Des Devel Ther 4:343–366. doi: 10.2147/DDDT.S9331
4. Muñoz-Culla M, Irizar H, Otaegui D (2013) The genetics of multiple sclerosis: review of current and emerging candidates. Appl Clin Genet 6:63–73. doi: 10.2147/TACG.S29107
5. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2 et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214–219. doi: 10.1038/nature10251
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra;Neurology, Neuropsychiatry, Psychosomatics;2024-06-22
2. Long-term outcomes of ADEM-like and tumefactive presentations of CNS demyelination: a case-comparison analysis;Journal of Neurology;2024-06-11
3. Advanced MRI Techniques: Diagnosis and Follow-Up of Multiple Sclerosis;Diagnostics;2024-05-28
4. The role of ocrelizumab in recommendations and in the Polish therapeutic programme;Aktualności Neurologiczne;2023-12-28
5. The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial;Journal of Neurology;2023-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3